Chronic myeloid leukemia (CML) is a disease driven by a single molecular defect, the BCR-ABL translocation, which results in the activation and dysregulation of a large number of signaling pathways, speeding up cell division and incorporation of genetic abnormalities [23]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.